Psychosocial Intervention for Suicidal Ideation in Individuals With FEP: A Feasibility Trial (CMAP-FEP)
Self Harm, First Episode Psychosis
About this trial
This is an interventional treatment trial for Self Harm, First Episode Psychosis focused on measuring Self-harm, First Episode Psychosis, adaptation, problem-solving.
Eligibility Criteria
Inclusion Criteria: Individuals diagnosed with FEP, Schizophrenia or Schizoaffective disorder according to DSM-V, confirmed by treating consultant. Age 18-35 years able to understand written and spoken Urdu. A score of 1 (Mild- Frequent thoughts of being better off dead, or occasional thoughts of suicide.) on the Calgary depression Scale item 8 (Suicide) "Have you felt that life wasn't worth living? Did you ever feel like ending it all? What did you think you might do? Did you actually try?" Individuals with a score of 3 or more on any of the positive symptoms on the Positive and Negative Syndrome Scale (PANSS) (e.g., delusions, hallucination). Exclusion Criteria: Any evidence of organic brain disease, clinically significant comorbid illness or learning disability. Participants deemed actively suicidal by their designated health professional. Those scoring >1 on Calgary depression Scale will be excluded and be referred to a psychiatric service.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
CMAP Plus FEP
treatment as usual
Participants with First episode of psychosis, Culturally Adapted Manual Assisted Problem Solving (CMAP) integrated with Culturally adapted Cognitive Behavior Therapy (CaCBT)
Participants in this group will continue their routine treatment as prescribed by their responsible clinician. In Pakistan TAU mostly comprise of antipsychotics with few patients having access to psychological therapies. Research staff will record the nature and intensity of the TAU for each participant